We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel 3D Imaging Technique Provides New Tool for Detecting Advanced Liver Fibrosis

By MedImaging International staff writers
Posted on 12 Apr 2016
Researchers have found that a new innovative 3D Magnetic Resonance Elastography (MRE) technique is a highly accurately, and less invasive method to diagnosis advanced liver fibrosis, instead of liver biopsies used today.

Non-Alcoholic Fatty Liver Disease occurs when large droplets of fat are deposited in the liver (hepatic steatosis), and can progress to liver fibrosis, cirrhosis, and cancer. NAFLD is widespread around the globe, and affects 33% or more of the general population in the US, and 50% of obese people.

The research was carried out at the UC San Diego School of Medicine NAFLD Research Center (San Diego, CA, USA) and published in the March 22, 2016, issue of the American Journal of Gastroenterology. The researchers conducted a prospective study that included 100 patients, 56% of them women, that had proven NAFLD. The researchers then assessed the effectiveness of 2D, and the new 3D MRE method. MRE is an Magnetic Resonance Imaging (MRI) technique that propagates mechanical shear waves in liver tissue. Tissue stiffness, an indicator of fibrosis, is measured quantitatively using an algorithm in MRE images.

Rohit Loomba, MD, director of the NAFLD Research Center, and first author of the study, said, “3D MRE is probably the most accurate noninvasive method to detect advanced fibrosis. The prospective study is the first to evaluate 3D-MRE for diagnosing advanced fibrosis in NAFLD patients. Both 2D and 3D were highly accurate. These findings suggest that MRE could be used to enroll patients with advanced fibrosis into screening programs for cirrhosis as well as enrollment into clinical trials aimed at reversing fibrosis in the setting of advanced fibrosis.”

Related Links:

UCSD School of Medicine NAFLD Research Center


Pocket Fetal Doppler
CONTEC10C/CL
X-ray Diagnostic System
FDX Visionary-A
Post-Processing Imaging System
DynaCAD Prostate
Portable X-ray Unit
AJEX140H

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.